Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MN Propolis is a leading Brazilian manufacturer and exporter of high-quality bee-derived products, specializing in organic Green Propolis. Founded in 1982 and headquartered in Mogi das Cruzes, the company integrates traditional apiculture with modern biotechnology to produce a wide range of health supplements, functional foods, and cosmetics. Their flagship products are rich in Artepillin C, a bioactive compound known for its potent antioxidant, anti-inflammatory, and immune-modulating properties. MN Propolis maintains a strong international presence, exporting to over 30 countries, with a particularly significant market share in Japan. The company is committed to sustainability and scientific rigor, holding numerous certifications including GMP, ISO 9001, and various international organic seals. Through continuous research and development, MN Propolis remains at the forefront of the natural health industry, providing standardized and safe propolis-based solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MN Propolis.